Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +751.11%
#3 ADO Protocol ADO Protocol +101.14%
#4 Cortex Cortex +92.99%
#5 Ontology Gas Ontology Gas +77.68%
#6 Kinesis Silver Kinesis Silver +54.16%
#7 OpenEden OpenEden +35.10%
#8 Biconomy Biconomy +28.11%
#9 Magma Finance Magma Finance +26.20%
#10 QuantixAI QuantixAI +23.21%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Flerie AB (publ) Flerie AB (publ)

Flerie AB (publ)

FLERIE
Rang in Aktien #18881
Flerie AB (publ) functions as a venture capital entity, concentrating its... Flerie AB (publ) functions as a venture capital entity, concentrating its investments on nascent businesses. The firm actively seeks to fund biotechnology and pharmaceutical companies dedicated to advancing drug discovery and development, or producing innovative tools and applications aimed at addressing pressing global health concerns. Geographically, their investment scope includes Europe, the United States, and Israel. Founded in 2011, Flerie AB (publ) is headquartered in Stockholm, Sweden, and also operates a branch office in London, United Kingdom.
Aktienkurs
$2.11
Marktkapitalisierung
$183.02M
Veränderung (1 Tag)
-1.82%
Veränderung (1 Jahr)
-45.27%
Land
SE
Handel Flerie AB (publ) (FLERIE)

Kategorie

Healthcare
Kursverlauf für Flerie AB (publ) (FLERIE)
Höchster Schlusskurs: $2.21 am 2026-08-01

Niedrigster Schlusskurs: $4.24 am 2024-06-01
Kursverlauf der Aktie von Flerie AB (publ) von 2024 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -7.90%
2025 -7.26%
2024 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.20K 62.79%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $270.18 53.09%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $260.78 25.16%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $487.19 44.15%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $153.58 80.70%
US